ATNM Financials
Actinium Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$1.00
Market Cap
$33.88M
P/E Ratio
-0.5
EPS
$-1.04
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-38.24M
EPS (Diluted)
$-1.27
Balance Sheet Highlights
Total Assets
$76.90M
Total Liabilities
$44.14M
Shareholders Equity
-
Cash & Equivalents
$72.90M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-33.07M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-6324.4%
ROE
-133.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ATNM revenue?
View ATNM's income statement for detailed revenue data.
Is ATNM profitable?
ATNM reported a loss of $38.24M in the most recent quarter.
What is ATNM market cap?
ATNM has a market capitalization of $33.88M, making it a small-cap stock.
Does ATNM have debt?
View ATNM's balance sheet for debt information.
What is ATNM cash flow?
Cash flow data is available in the full financial statements.